Access To Medicine Foundation | Access to Medicine Foundation

ACCESS TO MEDICINE INDEX 2022

Featured insights

Discover the latest at the Foundation

Gas companies took action during COVID-19. Now they must expand access to medical oxygen over the long term.

New Supervisory Board members Linda-Gail Bekker and Mariângela Simão bring a world of experience

Explore per sector

R&D-based pharma companies

We encourage them to make their products accessible.

Generic medicine manufacturers

We empower the industry to become more responsive.

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Vaccine manufacturers

We guide them to improve access to immunisation.

Resource centre

Explore our research reports and publications

Featured Key findings

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022

Featured Research

The Methodology for the 2022 Access to Medicine Index

22 September 2021

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022

How companies compare

Learn more about how pharmaceutical companies perform in the Access to Medicine Index

Explore our cross-sector programmes

Antimicrobial resistance programme

Diabetes care programme

Events and engagements

SHARING OUR INSIGHTS TO HELP DRIVE CHANGE

ASCO 2023 Annual Meeting: Access to Essential Medicines

Suzi van Es to join panel discussion on how investors can address AMR

AHB Symposium 2023: Mary Moehlmann to speak on lessons learnt from COVID-19

From insulin to glucose self-monitoring devices: ramping up access along the diabetes continuum of care

Media coverage

Read more about our coverage in global media

Poor countries desperately need better access to generic medicines

15 February 2023

Framework to assess, nudge generic drug makers to expand access to products

15 February 2023